| Net Cash Provided by (Used in) Operating Activities |
-8.98K |
USD |
+7.09% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
-100% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q4 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
75M |
shares |
0% |
Q2 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
7.83M |
shares |
0% |
Q2 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
893 |
USD |
-88.8% |
Q2 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
16.2K |
USD |
+35.7% |
Q2 2025 |
Q3 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q4 2024 |
Q1 2025 |
| Depreciation |
0 |
USD |
-100% |
Q4 2024 |
Q1 2025 |
| Payments to Acquire Property, Plant, and Equipment |
0 |
USD |
|
Q4 2024 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
961 |
USD |
|
Q2 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
77K |
USD |
+35.7% |
Q2 2025 |
Q3 2025 |
| Additional Paid in Capital |
25.4K |
USD |
0% |
Q2 2025 |
Q3 2025 |